The Effect of the GLP-1 Analogue Exenatide on Glucose Metabolism in the CNS and Heart During Hyperglycemia in Type-2 Diabetic Patients Assessed by PET.
Phase of Trial: Phase II/III
Latest Information Update: 29 Jun 2011
At a glance
- Drugs Exenatide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 10 Jun 2017 Biomarkers information updated
- 29 Jun 2011 Actual trial end date (Mar 2011) added as reported by ClinicalTrials.gov.
- 29 Jun 2011 Additional lead trial investigator (Michael Gejl Jensen) added as reported by ClinicalTrials.gov.